EA201992448A1 - Лечение бактериальной вагинальной инфекции - Google Patents

Лечение бактериальной вагинальной инфекции

Info

Publication number
EA201992448A1
EA201992448A1 EA201992448A EA201992448A EA201992448A1 EA 201992448 A1 EA201992448 A1 EA 201992448A1 EA 201992448 A EA201992448 A EA 201992448A EA 201992448 A EA201992448 A EA 201992448A EA 201992448 A1 EA201992448 A1 EA 201992448A1
Authority
EA
Eurasian Patent Office
Prior art keywords
treatment
vaginal infection
bacterial vaginal
bacterial
infection
Prior art date
Application number
EA201992448A
Other languages
English (en)
Inventor
Сильва Бердзик-Каларус
Даниэль Суликовски
Original Assignee
Адамед Фарма С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Адамед Фарма С.А. filed Critical Адамед Фарма С.А.
Publication of EA201992448A1 publication Critical patent/EA201992448A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Настоящее изобретение относится к фуразидину для вагинального применения при лечении бактериальной вагинальной инфекции. Предпочтительно бактериальная вагинальная инфекция вызвана бактериями Gardnerella vaginalis и/или Atopobium vaginae.
EA201992448A 2017-04-14 2018-04-03 Лечение бактериальной вагинальной инфекции EA201992448A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17461524.5A EP3388063A1 (en) 2017-04-14 2017-04-14 Treatment of a bacterial vaginal infection
PCT/EP2018/058508 WO2018188992A1 (en) 2017-04-14 2018-04-03 Treatment of a bacterial vaginal infection

Publications (1)

Publication Number Publication Date
EA201992448A1 true EA201992448A1 (ru) 2020-02-17

Family

ID=58578922

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201992448A EA201992448A1 (ru) 2017-04-14 2018-04-03 Лечение бактериальной вагинальной инфекции

Country Status (11)

Country Link
US (2) US11684608B2 (ru)
EP (2) EP3388063A1 (ru)
BR (1) BR112019021404A2 (ru)
CO (1) CO2019011305A2 (ru)
CR (1) CR20190466A (ru)
EA (1) EA201992448A1 (ru)
MX (1) MX2019012232A (ru)
MY (1) MY196293A (ru)
PH (1) PH12019502332A1 (ru)
SG (1) SG11201909562PA (ru)
WO (1) WO2018188992A1 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3388063A1 (en) 2017-04-14 2018-10-17 Adamed sp. z o.o. Treatment of a bacterial vaginal infection
US11529346B2 (en) * 2020-06-18 2022-12-20 National Medical Supply, LLC Vaginal gel

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4500516A (en) * 1982-10-22 1985-02-19 Institut Organicheskogo Sinteza Akademii Nauk Latviiskoi Ssr Antibacterial pharmaceutical composition
US4542020A (en) * 1984-08-17 1985-09-17 E. R. Squibb & Sons, Inc. Long-lasting adhesive antifungal suppositories
CA2008775C (en) 1989-02-24 1998-12-22 Alberto Ferro Nail lacquer
US20020160444A1 (en) * 2000-08-11 2002-10-31 Whitehead Institute For Biomedical Research Control of biofilm development
JP2004067599A (ja) * 2002-08-07 2004-03-04 Kunihiko Tominaga 腟内洗浄剤
WO2012106264A2 (en) * 2011-01-31 2012-08-09 The Trustees Of Columbia University In The City Of New York Treatment and prevention of bacterial vaginosis and gardnerella vaginalis infections
EP3388063A1 (en) 2017-04-14 2018-10-17 Adamed sp. z o.o. Treatment of a bacterial vaginal infection

Also Published As

Publication number Publication date
PH12019502332A1 (en) 2020-10-12
CR20190466A (es) 2019-11-15
WO2018188992A1 (en) 2018-10-18
EP3388063A1 (en) 2018-10-17
SG11201909562PA (en) 2019-11-28
US20230270725A1 (en) 2023-08-31
MX2019012232A (es) 2019-11-28
CO2019011305A2 (es) 2019-10-31
US20200078337A1 (en) 2020-03-12
BR112019021404A2 (pt) 2020-04-28
EP3609493A1 (en) 2020-02-19
US11684608B2 (en) 2023-06-27
EP3609493B1 (en) 2024-05-15
MY196293A (en) 2023-03-24

Similar Documents

Publication Publication Date Title
EA201991556A1 (ru) Ингибиторы фосфодиэстеразы и способы лечения микробной инфекции
EA201692303A1 (ru) Новая противоинфекционная стратегия против коинфекций, вызванных вирусом гриппа и s.aureus
CL2018002774A1 (es) Detección de infección microbiana en heridas
EA201390274A1 (ru) Борсодержащие малые молекулы
EA201270566A1 (ru) Противомикробные соединения и способы их получения и применения
EA201270567A1 (ru) Противомикробные соединения и способы их получения и применения
EA202091118A1 (ru) Антибактериальные соединения
EA201690687A1 (ru) Ингибиторы репликации вируса иммунодефицита
ES2571998T3 (es) Composiciones y usos médicos de derivados del ajoeno
EA201990551A1 (ru) Антибиотические соединения
EA201692358A1 (ru) Производные изоиндолина для применения в лечении вирусной инфекции
EA201591362A1 (ru) Соединения и способы лечения бактериальных инфекций
MX2017009094A (es) Derivado de polimixina y usos del mismo.
UA107346C2 (en) Use of nifuratel to treat infections caused by atopobium species
EA201500913A1 (ru) Противомикробные соединения и способы их получения и применения
EA201992448A1 (ru) Лечение бактериальной вагинальной инфекции
EA201791051A1 (ru) Способ лечения, профилактики или снижения риска возникновения кожной инфекции
EA202090266A1 (ru) Ингибиторы mpo для применения в медицине
WO2019040105A3 (en) COMPOUNDS, SALTS THEREOF AND METHODS FOR THE TREATMENT OF DISEASES
EA201390925A1 (ru) Производные санглиферина и способы их получения
DK3432900T3 (da) Mælkesyrebakteriesammensæting til behandling af bakterielle vaginale infektioner forårsaget af gardnerella vaginalis og, hvis de forefindes, samtidige svampeinfektioner
EA202092045A1 (ru) Лечение и предупреждение преэклампсии
EA202090728A1 (ru) Применение нор-урсодезоксихолевой кислоты для снижения печеночного жира
EA202192716A1 (ru) Состав вагинальных таблеток
PL425327A1 (pl) Zastosowanie α,β,2',3'-tetrahydroksantohumolu